Pacira BioSciences, Inc. 8-K

What Happened
Pacira BioSciences, Inc. announced its financial results for the quarter ended March 31, 2026 by issuing a press release dated April 30, 2026. The company furnished the full text of that press release as Exhibit 99.1 to its Current Report on Form 8‑K (filed April 30, 2026) under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Press release announcing quarterly results dated April 30, 2026 and covers Q1 ended March 31, 2026.
• The press release text is furnished as Exhibit 99.1 to the Form 8‑K.
• Form 8‑K filed April 30, 2026 (Item 2.02 disclosure of earnings/financial results).
• Report signed by Kristen Williams, Chief Administrative Officer and Secretary.

Why It Matters
This 8‑K signals that Pacira has publicly reported its quarterly earnings and related financial information; investors should review the April 30, 2026 press release (Exhibit 99.1) for details on revenue, net income/loss, and other quarterly metrics. The filing itself confirms the timing and availability of those quarterly results but does not restate the financial figures — see the furnished press release for the specific numbers.